Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology

TDP-43 pathology is a hallmark of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal lobar degeneration (FTLD). Namely, both diseases feature aggregated and phosphorylated TDP-43 containing inclusions in the cytoplasm and a loss of nuclear TDP-43 in affected neurons. It has been reported that ta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuan Tian, Yi Wang, Angela M. Jablonski, Yinghui Hu, Jonathan A. Sugam, Markus Koglin, Shawn J. Stachel, Heather Zhou, Jason M. Uslaner, Sophie Parmentier-Batteur
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
ALS
Acceso en línea:https://doaj.org/article/10127822ae8a4b869c780c0f430e8e11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:10127822ae8a4b869c780c0f430e8e11
record_format dspace
spelling oai:doaj.org-article:10127822ae8a4b869c780c0f430e8e112021-12-04T04:33:12ZTau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology1095-953X10.1016/j.nbd.2021.105548https://doaj.org/article/10127822ae8a4b869c780c0f430e8e112021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0969996121002977https://doaj.org/toc/1095-953XTDP-43 pathology is a hallmark of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal lobar degeneration (FTLD). Namely, both diseases feature aggregated and phosphorylated TDP-43 containing inclusions in the cytoplasm and a loss of nuclear TDP-43 in affected neurons. It has been reported that tau tubulin kinase (TTBK)1/2 phosphorylate TDP-43 and TTBK1/2 overexpression induced neuronal loss and behavioral deficits in a C. elegans model of ALS. Here we aimed to elucidate the molecular mechanisms of TTBK1 in TDP-43 pathology. TTBK1 levels were observed to be elevated in ALS patients' post-mortem motor cortex. Also, TTBK1 was found to phosphorylate TDP-43 at disease-relevant sites in vitro directly, and this phosphorylation accelerated TDP-43 formation of high molecular species. Overexpression of TTBK1 in mammalian cells induced TDP-43 phosphorylation and the construction of high molecular species, concurrent with TDP-43 mis-localization and cytoplasmic inclusions. In addition, when TTBK1 was knocked down or pharmacologically inhibited, TDP-43 phosphorylation and aggregation were significantly alleviated. Functionally, TTBK1 knockdown could rescue TDP-43 overexpression-induced neurite and neuronal loss in iPSC-derived GABAergic neurons. These findings suggest that phosphorylation plays a critical role in the pathogenesis of TDP-43 pathology and that TTBK1 inhibition may have therapeutic potential for the treatment of ALS and FTLD.Yuan TianYi WangAngela M. JablonskiYinghui HuJonathan A. SugamMarkus KoglinShawn J. StachelHeather ZhouJason M. UslanerSophie Parmentier-BatteurElsevierarticleTTBK1ALSFTLDTDP-43PathologyPhosphorylationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENNeurobiology of Disease, Vol 161, Iss , Pp 105548- (2021)
institution DOAJ
collection DOAJ
language EN
topic TTBK1
ALS
FTLD
TDP-43
Pathology
Phosphorylation
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle TTBK1
ALS
FTLD
TDP-43
Pathology
Phosphorylation
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Yuan Tian
Yi Wang
Angela M. Jablonski
Yinghui Hu
Jonathan A. Sugam
Markus Koglin
Shawn J. Stachel
Heather Zhou
Jason M. Uslaner
Sophie Parmentier-Batteur
Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
description TDP-43 pathology is a hallmark of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal lobar degeneration (FTLD). Namely, both diseases feature aggregated and phosphorylated TDP-43 containing inclusions in the cytoplasm and a loss of nuclear TDP-43 in affected neurons. It has been reported that tau tubulin kinase (TTBK)1/2 phosphorylate TDP-43 and TTBK1/2 overexpression induced neuronal loss and behavioral deficits in a C. elegans model of ALS. Here we aimed to elucidate the molecular mechanisms of TTBK1 in TDP-43 pathology. TTBK1 levels were observed to be elevated in ALS patients' post-mortem motor cortex. Also, TTBK1 was found to phosphorylate TDP-43 at disease-relevant sites in vitro directly, and this phosphorylation accelerated TDP-43 formation of high molecular species. Overexpression of TTBK1 in mammalian cells induced TDP-43 phosphorylation and the construction of high molecular species, concurrent with TDP-43 mis-localization and cytoplasmic inclusions. In addition, when TTBK1 was knocked down or pharmacologically inhibited, TDP-43 phosphorylation and aggregation were significantly alleviated. Functionally, TTBK1 knockdown could rescue TDP-43 overexpression-induced neurite and neuronal loss in iPSC-derived GABAergic neurons. These findings suggest that phosphorylation plays a critical role in the pathogenesis of TDP-43 pathology and that TTBK1 inhibition may have therapeutic potential for the treatment of ALS and FTLD.
format article
author Yuan Tian
Yi Wang
Angela M. Jablonski
Yinghui Hu
Jonathan A. Sugam
Markus Koglin
Shawn J. Stachel
Heather Zhou
Jason M. Uslaner
Sophie Parmentier-Batteur
author_facet Yuan Tian
Yi Wang
Angela M. Jablonski
Yinghui Hu
Jonathan A. Sugam
Markus Koglin
Shawn J. Stachel
Heather Zhou
Jason M. Uslaner
Sophie Parmentier-Batteur
author_sort Yuan Tian
title Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
title_short Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
title_full Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
title_fullStr Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
title_full_unstemmed Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
title_sort tau-tubulin kinase 1 phosphorylates tdp-43 at disease-relevant sites and exacerbates tdp-43 pathology
publisher Elsevier
publishDate 2021
url https://doaj.org/article/10127822ae8a4b869c780c0f430e8e11
work_keys_str_mv AT yuantian tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT yiwang tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT angelamjablonski tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT yinghuihu tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT jonathanasugam tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT markuskoglin tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT shawnjstachel tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT heatherzhou tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT jasonmuslaner tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
AT sophieparmentierbatteur tautubulinkinase1phosphorylatestdp43atdiseaserelevantsitesandexacerbatestdp43pathology
_version_ 1718372952674664448